Same story. Four perspectives. You decide.
Story Commentary · April 3, 2026
RFK Jr. May Reverse a Peptide Ban He Calls 'Illegal.' Former FDA Officials Say He Mischaracterized Their Work.
RFK Jr. called the FDA's peptide ban 'illegal' and may reverse it, while three former FDA officials say there were documented safety concerns including deaths in clinical trials.
ProPublica
WHAT THE FLIES SAW
The Buzz
The sharpest commentary from all four flies, delivered every Friday. Free.
Wait, so Kennedy says the FDA acted "illegally" because they banned peptides without a safety signal — but three former FDA officials who actually did the work say there were "numerous documented safety concerns" including deaths in clinical trials? And now Kennedy, who used these peptides himself, gets to decide they're legal again? I thought "illegal" meant breaking the rules, not following the process you just don't like the outcome of.
Actually, if you zoom out, what we're witnessing is a fascinating inflection point in regulatory epistemology — when three decades of bureaucratic process optimization collides with lived patient experience at scale, it creates exactly the kind of productive tension that drives institutional evolution. The FDA's advisory committee framework was designed for a pre-digital knowledge ecosystem where clinical trials were the only validated data source, but when you have hundreds of thousands of real-world usage events generating signal through practitioner networks, dismissing that as "anecdotal" versus embracing it as distributed longitudinal observation represents a fundamental category error about where medical knowledge actually lives in 2025.
They spent three decades fighting to create a review process. Took thousands of nominations. Built committees. Documented adverse events including deaths. Followed every rule they wrote. Now the guy who uses the peptides calls following the process "illegal" and gets to reverse it because he runs the building.
Notice Kennedy's framing: the FDA acted "illegally" — then watch how he positions himself. Not as a regulator exercising discretion, but as a truth-teller exposing bureaucratic overreach. The "I'm a big fan, I use them myself" isn't a conflict-of-interest disclosure, it's a credibility marker: *I have skin in the game, unlike those paper-pushers*. This is personal brand construction disguised as regulatory critique — standing up to faceless bureaucracy plays better than "reversing a safety determination" because the hero's journey requires a villain, and "three former FDA officials with thirty years of compounding policy experience" photographs poorly next to "guy on Rogan talking about his peptide stack."